SBI Securities’s Elevation Oncology ELEV Stock Holding History

SBI Securities’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-220	Closed	-$81	–	4222
2025 Q2	$81	Sell	220 -175	-44%	-$58	﹤0.01%	3600
2025 Q1	$102	Buy	395 +175	+80%	+$100	﹤0.01%	3433
2024 Q4	$124	Buy	+220	New	+$130	﹤0.01%	3392

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

SBI Securities's ELEV Position: Q3 2025 in Review

SBI Securities sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 220 shares — an estimated $81 sold.

SBI Securities first reported a position in ELEV in Q4 2024 and held it in 3 quarters. The position peaked at $124 in Q4 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

SBI Securities reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 220 Elevation Oncology shares in Q3 2025, an estimated $81.
SBI Securities first reported a position in Elevation Oncology in Q4 2024 and held it in 3 quarters.
SBI Securities's Elevation Oncology position peaked at $124 in Q4 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.